Mesenchymal Stromal/stem Cells and Their Extracellular Vesicles in Liver Diseases: Insights on Their Immunomodulatory Roles and Clinical Applications

Overview

Journal Cell Biosci

Publisher Biomed Central

Specialty Biology

Date 2023 Sep 5

PMID 37670393

Authors

Qian Huai

Cheng Zhu

Xu Zhang

Hanren Dai

Xiaolei Li

Hua Wang

Affiliations

Soon will be listed here.

Abstract

Liver disease is a leading cause of mortality and morbidity that is rising globally. Liver dysfunctions are classified into acute and chronic diseases. Various insults, including viral infections, alcohol or drug abuse, and metabolic overload, may cause chronic inflammation and fibrosis, leading to irreversible liver dysfunction. Up to now, liver transplantation could be the last resort for patients with end-stage liver disease. However, liver transplantation still faces unavoidable difficulties. Mesenchymal stromal/stem cells (MSCs) with their broad ranging anti-inflammatory and immunomodulatory properties can be effectively used for treating liver diseases but without the limitation that are associated with liver transplantation. In this review, we summarize and discuss recent advances in the characteristics of MSCs and the potential action mechanisms of MSCs-based cell therapies for liver diseases. We also draw attention to strategies to potentiate the therapeutic properties of MSCs through pre-treatments or gene modifications. Finally, we discuss progress toward clinical application of MSCs or their extracellular vesicles in liver diseases.

Citing Articles

Mesenchymal Stem Cell-Derived Extracellular Vesicles for Regenerative Applications and Radiotherapy.

Wang N, Ma F, Song H, He N, Zhang H, Li J Cell Transplant. 2025; 34():9636897241311019.

PMID: 39780320 PMC: 11713979. DOI: 10.1177/09636897241311019.

A comprehensive evaluation system for ultrasound-guided infusion of human umbilical cord-derived MSCs in liver cirrhosis patients.

Zhou G, You Y, Wang B, Wang S, Feng T, Lai C Stem Cells Transl Med. 2024; 14(1).

PMID: 39520328 PMC: 11821905. DOI: 10.1093/stcltm/szae081.

Precision Nanomedicine with Bio-Inspired Nanosystems: Recent Trends and Challenges in Mesenchymal Stem Cells Membrane-Coated Bioengineered Nanocarriers in Targeted Nanotherapeutics.

Baig M, Ahmad A, Pathan R, Mishra R J Xenobiot. 2024; 14(3):827-872.

PMID: 39051343 PMC: 11270309. DOI: 10.3390/jox14030047.

Mesenchymal stem/stromal cells armored by FGF21 ameliorate alcohol-induced liver injury through modulating polarization of macrophages.

Huai Q, Zhu C, Zhang X, Dai H, Li X, Wang H Hepatol Commun. 2024; 8(4).

PMID: 38551384 PMC: 10984668. DOI: 10.1097/HC9.0000000000000410.

Invigorating human MSCs for transplantation therapy via Nrf2/DKK1 co-stimulation in an acute-on-chronic liver failure mouse model.

Chen F, Che Z, Liu Y, Luo P, Xiao L, Song Y Gastroenterol Rep (Oxf). 2024; 12:goae016.

PMID: 38529014 PMC: 10963075. DOI: 10.1093/gastro/goae016.

References

Asrani S, Devarbhavi H, Eaton J, Kamath P . Burden of liver diseases in the world. J Hepatol. 2018; 70(1):151-171. DOI: 10.1016/j.jhep.2018.09.014. View

Aberg F, Byrne C, Pirola C, Mannisto V, Sookoian S . Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease. J Hepatol. 2022; 78(1):191-206. DOI: 10.1016/j.jhep.2022.08.030. View

Fan X, Zhang Y, Li X, Fu Q . Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell Mol Life Sci. 2020; 77(14):2771-2794. PMC: 7223321. DOI: 10.1007/s00018-020-03454-6. View

FRIEDENSTEIN A, Chailakhjan R, LALYKINA K . The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970; 3(4):393-403. DOI: 10.1111/j.1365-2184.1970.tb00347.x. View

Melief S, Zwaginga J, Fibbe W, Roelofs H . Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med. 2013; 2(6):455-63. PMC: 3673757. DOI: 10.5966/sctm.2012-0184. View

Baksh D, Yao R, Tuan R . Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007; 25(6):1384-92. DOI: 10.1634/stemcells.2006-0709. View

Cao L, Zhang Y, Qian M, Wang X, Shuai Q, Gao C . Construction of multicellular aggregate by E-cadherin coated microparticles enhancing the hepatic specific differentiation of mesenchymal stem cells. Acta Biomater. 2019; 95:382-394. DOI: 10.1016/j.actbio.2019.01.030. View

Lin H, Xu R, Zhang Z, Chen L, Shi M, Wang F . Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseases. Cell Mol Immunol. 2011; 8(1):19-22. PMC: 4002992. DOI: 10.1038/cmi.2010.57. View

Wang Y, Chen X, Cao W, Shi Y . Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol. 2014; 15(11):1009-16. DOI: 10.1038/ni.3002. View

10.

Wang Y, Fang J, Liu B, Shao C, Shi Y . Reciprocal regulation of mesenchymal stem cells and immune responses. Cell Stem Cell. 2022; 29(11):1515-1530. DOI: 10.1016/j.stem.2022.10.001. View

11.

Wang H, Mehal W, Nagy L, Rotman Y . Immunological mechanisms and therapeutic targets of fatty liver diseases. Cell Mol Immunol. 2020; 18(1):73-91. PMC: 7852578. DOI: 10.1038/s41423-020-00579-3. View

12.

Liu J, Gao J, Liang Z, Gao C, Niu Q, Wu F . Mesenchymal stem cells and their microenvironment. Stem Cell Res Ther. 2022; 13(1):429. PMC: 9391632. DOI: 10.1186/s13287-022-02985-y. View

13.

Malmir A, Farivar S, Rezaei R, Tokhanbigli S, Hatami B, Mazhari S . The effect of mesenchymal stem cells and imatinib on macrophage polarization in rat model of liver fibrosis. Cell Biol Int. 2022; 47(1):135-143. DOI: 10.1002/cbin.11916. View

14.

Francois M, Romieu-Mourez R, Li M, Galipeau J . Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther. 2011; 20(1):187-95. DOI: 10.1038/mt.2011.189. View

15.

Fang J, Zhang S, Liu Z, Pan Y, Cao L, Hou P . Skeletal muscle stem cells confer maturing macrophages anti-inflammatory properties through insulin-like growth factor-2. Stem Cells Transl Med. 2020; 9(7):773-785. PMC: 7308640. DOI: 10.1002/sctm.19-0447. View

16.

Liu Y, Lou G, Li A, Zhang T, Qi J, Ye D . AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3 inflammasome activation in macrophages. EBioMedicine. 2018; 36:140-150. PMC: 6197728. DOI: 10.1016/j.ebiom.2018.08.054. View

17.

Kolaczkowska E, Kubes P . Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013; 13(3):159-75. DOI: 10.1038/nri3399. View

18.

Das S, Maras J, Hussain M, Sharma S, David P, Sukriti S . Hyperoxidized albumin modulates neutrophils to induce oxidative stress and inflammation in severe alcoholic hepatitis. Hepatology. 2016; 65(2):631-646. DOI: 10.1002/hep.28897. View

19.

Ren R, He Y, Ding D, Cui A, Bao H, Ma J . Aging exaggerates acute-on-chronic alcohol-induced liver injury in mice and humans by inhibiting neutrophilic sirtuin 1-C/EBPα-miRNA-223 axis. Hepatology. 2021; 75(3):646-660. PMC: 8844214. DOI: 10.1002/hep.32152. View

20.

Wan Y, Li Z, Liu C, He Y, Wang M, Wu X . Mesenchymal stem cells reduce alcoholic hepatitis in mice via suppression of hepatic neutrophil and macrophage infiltration, and of oxidative stress. PLoS One. 2020; 15(2):e0228889. PMC: 7012433. DOI: 10.1371/journal.pone.0228889. View